Adrien Lemoine
Founder at Bloomsbury Genetic Therapies Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank Thomas | M | 54 | 6 years | |
| Andrea Spezzi | M | - |
Bloomsbury Genetic Therapies Ltd.
 Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | 2 years |
| John Ilett | M | - |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | 2 years |
| Michael Diem | M | - |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | - |
| Frank Armstrong | M | 67 |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | 2 years |
| Sylvie Grégoire | M | 62 |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | 8 years |
| Bobby Gaspar | M | 60 | 6 years | |
| Leslie Meltzer | M | - | 6 years | |
| Leigh Brody | M | - |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | 2 years |
| Sara Garcia Gomez | M | - |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Rothera | M | 61 | 2 years | |
| Elise T. Wang | F | 64 | - | |
| Joanne Beck | M | 63 | 6 years | |
| Marc Dunoyer | M | 71 | 6 years | |
| Steven Altschuler | M | 70 | 4 years | |
| Charles Rowland | M | 65 | 6 years | |
| Alexander Pasteur | M | 54 | - | |
| John Curnutte | M | 72 | 5 years | |
| Alicia Secor | F | 62 | 6 years | |
| James Geraghty | M | 69 | 6 years | |
| Nicolas Koebel | M | - | - | |
| Simone Song | F | 59 | - | |
| Jon Ellis | M | 57 | 3 years | |
| Molly Cameron | F | - | - | |
| Ran Zheng | F | 61 | 2 years | |
| Moya M. Daniels | F | 55 | 2 years | |
| NgocDiep Le | M | 56 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | 2 years |
| Jason Meyenburg | M | 47 | 1 years | |
| Leila Alland | M | 61 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | 2 years |
| Stewart Craig | M | 63 | 3 years | |
| Niamh Alix | F | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 28 | 90.32% |
| United States | 3 | 9.68% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Adrien Lemoine
- Personal Network
